Biomedical Laboratory Science

ShareThis

Showing posts with label Invasive. Show all posts
Showing posts with label Invasive. Show all posts

Friday, June 1, 2018

What is a free PSA test and what is it for?


"The free prostate-specific antigen test, known as the free PSA test, is used to help detect signs of prostate cancer. The test measures the level of unbound prostate-specific antigen in the blood, which can help doctors to diagnose issues like inflammation of the prostate or cancer."
Free PSA tests are often used alongside other PSA tests to confirm a diagnosis or test results. Free PSA tests can also be used instead of a biopsy if the doctor suspects prostate cancer, but a biopsy may still be needed.


This article examines when a free PSA test is used, how it differs from a total PSA test, and what the results mean.

Sunday, September 4, 2016

If You Are In Danger Of BREAST CANCER, Your Body Will Give You These 5 Signs!

Invasive breast cancer affects 1 in 8 women in the US only. It’s the type of cancer with the highest incidence among women. According to the American Cancer Society, by the end of 2016, 246,660 new cases of invasive breast cancer will be diagnosed in America, 40,450 of which will be terminal.
Detecting the cancer early significantly increases the chances of successful treatment. Knowing the early signs and symptoms of invasive breast cancer can help you detect it in its early stages.
  1. FATIGUE
Fatigue is a common symptom in many types of cancer, including breast cancer. The thing is this type of fatigue cannot be alleviated by sleep or rest. Cancer-related fatigue is not caused by physical strain and is often accompanied by other symptoms such as pain, sleep disturbance and depression. This fatigue is caused by an imbalance of chemicals in the body the cancer creates, according to scientists.




Tuesday, July 26, 2016

Colorecal Cancer: Minimally Invasive, Triple-Therapy Patch Destroys Tumors

Research released by the Massachusetts Institute of Technology describes an adhesive patch that can deliver a triple-combination of drug, gene, and light-based therapy to colorectal tumors.

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. The lifetime risk of developing colorectal cancer is 1 in 21 for men and 1 in 23 for women.

Most colorectal cancers begin as a growth, or tumor, on the inner lining of the colon or rectum called a polyp, and they can change to cancer over many years. Not all polyps become cancer.

It usually takes around 10-15 years for abnormal cells to grow into colorectal tumors. With regular screening, polyps can be removed before they develop into cancer.

Although the type of treatment for colorectal cancer largely depends on the stage of cancer, treatment options are often surgery, chemotherapy, and radiation therapy.


The triple-therapy patch could be used to treat any remaining cancer cells at the tumor site after surgery.
Related Posts Plugin for WordPress, Blogger...

AddToAny